Novo Nordisk A/S (NVO)
128.45
-0.21
(-0.16%)
USD |
NYSE |
May 10, 16:00
128.18
-0.27
(-0.21%)
After-Hours: 20:00
Novo Nordisk Market Cap: 572.22B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 573.16B |
| May 08, 2024 | 564.38B |
| May 07, 2024 | 567.06B |
| May 06, 2024 | 555.03B |
| May 03, 2024 | 548.93B |
| May 02, 2024 | 553.26B |
| May 01, 2024 | 576.41B |
| April 30, 2024 | 572.40B |
| April 29, 2024 | 566.05B |
| April 26, 2024 | 565.92B |
| April 25, 2024 | 561.19B |
| April 24, 2024 | 562.84B |
| April 23, 2024 | 573.90B |
| April 22, 2024 | 558.83B |
| April 19, 2024 | 547.45B |
| April 18, 2024 | 547.65B |
| April 17, 2024 | 555.59B |
| April 16, 2024 | 550.78B |
| April 15, 2024 | 552.78B |
| April 12, 2024 | 555.51B |
| April 11, 2024 | 559.50B |
| April 10, 2024 | 557.41B |
| April 09, 2024 | 557.09B |
| April 08, 2024 | 568.69B |
| April 05, 2024 | 561.55B |
| Date | Value |
|---|---|
| April 04, 2024 | 553.10B |
| April 03, 2024 | 566.62B |
| April 02, 2024 | 564.25B |
| April 01, 2024 | 569.12B |
| March 28, 2024 | 572.91B |
| March 27, 2024 | 571.35B |
| March 26, 2024 | 577.43B |
| March 25, 2024 | 575.82B |
| March 22, 2024 | 574.53B |
| March 21, 2024 | 579.33B |
| March 20, 2024 | 581.70B |
| March 19, 2024 | 586.20B |
| March 18, 2024 | 592.99B |
| March 15, 2024 | 590.67B |
| March 14, 2024 | 600.55B |
| March 13, 2024 | 595.69B |
| March 12, 2024 | 602.92B |
| March 11, 2024 | 585.65B |
| March 08, 2024 | 593.82B |
| March 07, 2024 | 606.56B |
| March 06, 2024 | 556.71B |
| March 05, 2024 | 556.27B |
| March 04, 2024 | 570.99B |
| March 01, 2024 | 554.39B |
| February 29, 2024 | 534.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
111.20B
Minimum
May 16 2019
606.56B
Maximum
Mar 07 2024
251.21B
Average
231.23B
Median
Jan 07 2022
Market Cap Benchmarks
| Amgen Inc | 166.37B |
| Vertex Pharmaceuticals Inc | 109.11B |
| Viking Therapeutics Inc | 8.122B |
| Evaxion Biotech AS | 19.66M |
| Moderna Inc | 44.96B |
Market Cap Related Metrics
| PE Ratio | 44.34 |
| PS Ratio | 16.21 |
| PEG Ratio | 0.8394 |
| Price to Book Value | 39.99 |
| Price to Free Cash Flow | 78.58 |
| Price | 128.45 |
| Earnings Yield | 2.26% |
| PEGY Ratio | 0.8229 |
| Operating PE Ratio | 36.17 |
| Normalized PE Ratio | 44.34 |